Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| CODX | Co-Diagnostics | $2.36 | -$3.62 | -60.53% | 781.2K | $13M | $2.36$46.50 |
| TVTX | Travere Therapeutics | $22.71 | -$11.39 | -33.39% | 9.8M | $3.1B | $12.91$42.13 |
| ELAB | Pmgc | $4.03 | -$1.24 | -23.53% | 411.2K | $2.7M | $3.54$398.86 |
| AKAN | Akanda | $2.02 | -$0.61 | -23.19% | 854.2K | $1.9M | $1.86$46.45 |
| ATRA | Atara Biotherapeutics | $4.57 | -$1.31 | -22.28% | 1.9M | $42M | $4.43$19.15 |
| EMAT | Evolution Metals & Technologies | $13.25 | -$3.20 | -19.45% | 49K | $47M | $7.05$24.37 |
| RGC | Regencell Bioscience | $35.89 | -$8.22 | -18.64% | 571K | $22B | $0.09$83.60 |
| FIGG | Themes ETF Trust - Leverage Shares 2x Long Fig Daily ETF | $3.54 | -$0.77 | -17.90% | 857K | - | $3.53$16.34 |
| PASG | Passage Bio | $15.25 | -$2.67 | -14.88% | 53.8K | $56M | $5.12$20.00 |
| CRMG | Themes ETF Trust - Leverage Shares 2x Long Crm Daily ETF | $11.30 | -$1.76 | -13.48% | 453.4K | - | $9.86$19.41 |
Related Articles
Featured Article
A Nearly 1,100% Gain: Here's the 1 Key Reason Why This Forgotten Tech Stock Crushed the S&P 500
Scott Levine|Dec 5, 2025
After years of struggling with one key metric, this tech company has found its way back onto investors' buy lists.
This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)
Selena Maranjian|Nov 24, 2025
Is the stock likely to keep surging? The answer seems pretty clear.
This Fitness Tech Stock Has Crushed Apple's 2025 Gains -- 1 Reason Why
Lyle Daly|Oct 19, 2025
The Amazfit brand has helped Zepp Health bounce back in a big way after years of negative returns.
Advertisement
Could an FDA Approval Send This Stock Flying?
David Jagielski, CPA|Mar 1, 2023
Is now the time to load up on this struggling stock?
Is Semler Scientific Stock Still a Buy After Its Earnings Miss?
Jamie Louko|Nov 4, 2021
The company reported slowing growth, but is there hope?
This Top Small-Cap Just Became a Better Buy
Jamie Louko|Oct 2, 2021
With Semler moving to the Nasdaq, the company's strong business model will be more visible to investors.
Got $2,500? Check Out These 3 Alzheimer's Therapy Stocks
Alex Carchidi|Jul 17, 2021
Treating Alzheimer's is extremely difficult, but these innovative companies are taking a stab at it.
This Biotech Stock Is Up 884% In 2021, But It Could Go Even Higher
Alex Carchidi|Jun 10, 2021
With updates from clinical trials expected as soon as this month, anything is possible.
3 Biotech Stocks That Jumped Higher Last Week
Cory Renauer|May 23, 2021
Find out what pushed them up to see if the good times can keep rolling.
Co-Diagnostics: Buy the Dip?
Cory Renauer|Mar 29, 2021
Analysts following this coronavirus stock have darkened their post-pandemic outlook.
